Cargando…

Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study

BACKGROUND: Alterations in serum and membrane lipids may be involved in schizophrenia pathophysiology. It is not known whether lipid profiles are associated with disease severity or current symptom level. METHODS: Clinical and lipid data were gathered from 55 patients with schizophrenia admitted to...

Descripción completa

Detalles Bibliográficos
Autores principales: Solberg, Dag K., Bentsen, Håvard, Refsum, Helge, Andreassen, Ole A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000423/
https://www.ncbi.nlm.nih.gov/pubmed/27562545
http://dx.doi.org/10.1186/s12888-016-1006-3
_version_ 1782450280438169600
author Solberg, Dag K.
Bentsen, Håvard
Refsum, Helge
Andreassen, Ole A.
author_facet Solberg, Dag K.
Bentsen, Håvard
Refsum, Helge
Andreassen, Ole A.
author_sort Solberg, Dag K.
collection PubMed
description BACKGROUND: Alterations in serum and membrane lipids may be involved in schizophrenia pathophysiology. It is not known whether lipid profiles are associated with disease severity or current symptom level. METHODS: Clinical and lipid data were gathered from 55 patients with schizophrenia admitted to psychiatric emergency wards in an acute stage of the disease (T(1)). The patients were re-examined after 5 years at a stable phase (T(2)). The clinical assessments included Positive and Negative Syndrome Scale (PANSS total, positive, negative) and Global Assessment of Functioning (GAF S, symptom and F, function). Serum lipids (cholesterol and triglyceride) and membrane polyunsaturated fatty acids (PUFA, LCPUFA) were measured. Healthy controls were recruited among hospital workers. RESULTS: Serum triglyceride was significantly higher in patients with schizophrenia compared to healthy controls both at T(1) and T(2) (p < 0.001), while serum cholesterol did not differ significantly. The levels of serum lipids in patients remained stable over time. At T(1), serum lipids and symptoms were not significantly correlated. At T(2), higher serum lipids were associated with more severe symptoms and poorer functioning. Higher serum lipid levels at T(1) were associated with more severe symptoms and poorer functioning at T(2); cholesterol with GAF-S (p < 0.05), triglyceride with PANSS total (p < 0.05), GAF-S (p < 0.01) and GAF-F (p < 0.01). Membrane lipids were significantly lower in the patient group compared to healthy controls at T(1) (PUFA p < 0.001, LCPUFA p < 0.001), but not at T(2). Membrane lipids were not significantly correlated with symptoms at T(1), but significantly associated with negative symptoms and functioning at T(2) as previously reported. CONCLUSIONS: The present findings suggest different roles of membrane and serum lipids in schizophrenia pathophysiology. To further elucidate the relation of lipid biology to disease traits, replication in independent studies of longitudinal samples are warranted.
format Online
Article
Text
id pubmed-5000423
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50004232016-08-27 Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study Solberg, Dag K. Bentsen, Håvard Refsum, Helge Andreassen, Ole A. BMC Psychiatry Research Article BACKGROUND: Alterations in serum and membrane lipids may be involved in schizophrenia pathophysiology. It is not known whether lipid profiles are associated with disease severity or current symptom level. METHODS: Clinical and lipid data were gathered from 55 patients with schizophrenia admitted to psychiatric emergency wards in an acute stage of the disease (T(1)). The patients were re-examined after 5 years at a stable phase (T(2)). The clinical assessments included Positive and Negative Syndrome Scale (PANSS total, positive, negative) and Global Assessment of Functioning (GAF S, symptom and F, function). Serum lipids (cholesterol and triglyceride) and membrane polyunsaturated fatty acids (PUFA, LCPUFA) were measured. Healthy controls were recruited among hospital workers. RESULTS: Serum triglyceride was significantly higher in patients with schizophrenia compared to healthy controls both at T(1) and T(2) (p < 0.001), while serum cholesterol did not differ significantly. The levels of serum lipids in patients remained stable over time. At T(1), serum lipids and symptoms were not significantly correlated. At T(2), higher serum lipids were associated with more severe symptoms and poorer functioning. Higher serum lipid levels at T(1) were associated with more severe symptoms and poorer functioning at T(2); cholesterol with GAF-S (p < 0.05), triglyceride with PANSS total (p < 0.05), GAF-S (p < 0.01) and GAF-F (p < 0.01). Membrane lipids were significantly lower in the patient group compared to healthy controls at T(1) (PUFA p < 0.001, LCPUFA p < 0.001), but not at T(2). Membrane lipids were not significantly correlated with symptoms at T(1), but significantly associated with negative symptoms and functioning at T(2) as previously reported. CONCLUSIONS: The present findings suggest different roles of membrane and serum lipids in schizophrenia pathophysiology. To further elucidate the relation of lipid biology to disease traits, replication in independent studies of longitudinal samples are warranted. BioMed Central 2016-08-25 /pmc/articles/PMC5000423/ /pubmed/27562545 http://dx.doi.org/10.1186/s12888-016-1006-3 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Solberg, Dag K.
Bentsen, Håvard
Refsum, Helge
Andreassen, Ole A.
Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study
title Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study
title_full Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study
title_fullStr Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study
title_full_unstemmed Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study
title_short Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study
title_sort lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000423/
https://www.ncbi.nlm.nih.gov/pubmed/27562545
http://dx.doi.org/10.1186/s12888-016-1006-3
work_keys_str_mv AT solbergdagk lipidprofilesinschizophreniaassociatedwithclinicaltraitsafiveyearfollowupstudy
AT bentsenhavard lipidprofilesinschizophreniaassociatedwithclinicaltraitsafiveyearfollowupstudy
AT refsumhelge lipidprofilesinschizophreniaassociatedwithclinicaltraitsafiveyearfollowupstudy
AT andreassenolea lipidprofilesinschizophreniaassociatedwithclinicaltraitsafiveyearfollowupstudy